Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15 » default

Neuropsychiatric Disease and Treatment


Archive: Volume 15, 2019

An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study

Wester Oxelgren U, Westerlund J, Myrelid Å, Annerén G, Johansson L, Åberg M, Gustafsson J, Fernell E

Neuropsychiatric Disease and Treatment 2019, 15:2049-2056

Published Date: 18 July 2019

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

Mar J, Arrospide A, Soto-Gordoa M, Iruin Á, Tainta M, Gabilondo A, Mar-Barrutia L, Calvo M, Mateos M, Ibarrondo O

Neuropsychiatric Disease and Treatment 2019, 15:2027-2034

Published Date: 17 July 2019

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation

Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S

Neuropsychiatric Disease and Treatment 2019, 15:2003-2013

Published Date: 16 July 2019

Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats

Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M

Neuropsychiatric Disease and Treatment 2019, 15:1993-2002

Published Date: 16 July 2019

Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12)

Shinzato H, Koda M, Nakamura A, Kondo T

Neuropsychiatric Disease and Treatment 2019, 15:1983-1991

Published Date: 15 July 2019

Psychological factors associated with smoking and quitting: addiction map of Turkey study

Ünübol H, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2019, 15:1971-1982

Published Date: 11 July 2019

Heart rate variability and incidence of depression during the first six months following first myocardial infarction

Wilkowska A, Rynkiewicz A, Wdowczyk J, Landowski J, Cubała WJ

Neuropsychiatric Disease and Treatment 2019, 15:1951-1956

Published Date: 10 July 2019

Factors related to lithium blood concentrations in Chinese Han patients with bipolar disorder

Xu YY, Xia QH, Liang J, Cao Y, Shan F, Liu Y, Yan CY, Xia QR

Neuropsychiatric Disease and Treatment 2019, 15:1929-1937

Published Date: 10 July 2019

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease

Chang YP, Chou MC, Lai CL, Chien I, Yang YH

Neuropsychiatric Disease and Treatment 2019, 15:1915-1919

Published Date: 9 July 2019

Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies

Serino D, Santarone ME, Caputo D, Fusco L

Neuropsychiatric Disease and Treatment 2019, 15:1897-1903

Published Date: 9 July 2019

Developmental coordination disorder and dysgraphia: signs and symptoms, diagnosis, and rehabilitation

Biotteau M, Danna J, Baudou É, Puyjarinet F, Velay JL, Albaret JM, Chaix Y

Neuropsychiatric Disease and Treatment 2019, 15:1873-1885

Published Date: 8 July 2019

Antipsychotics and risk of natural death in patients with schizophrenia

Chen Y, Yang X, Qin X, Yang Q, Fan H, Li J, Song X, Xu S, Guo W, Deng W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1863-1871

Published Date: 5 July 2019

Validation of the Chinese version of the Health Cognitions Questionnaire in Chinese college students

Dai L, Xu Z, Yin M, Wang X, Deng Y

Neuropsychiatric Disease and Treatment 2019, 15:1845-1854

Published Date: 5 July 2019

Resting-state functional magnetic resonance imaging (fMRI) and functional connectivity density mapping in patients with corneal ulcer

Zhu F, Tang L, Zhu P, Lin Q, Yuan Q, Shi W, Li B, Ye L, Min Y, Su T, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:1833-1844

Published Date: 5 July 2019

QT and P-wave dispersion during the manic phase of bipolar disorder

Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M

Neuropsychiatric Disease and Treatment 2019, 15:1805-1811

Published Date: 3 July 2019

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study

Chiu LL, Liu CH, Chu CL, Lin HL, Lii SC

Neuropsychiatric Disease and Treatment 2019, 15:1797-1804

Published Date: 3 July 2019

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder

Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G

Neuropsychiatric Disease and Treatment 2019, 15:1771-1779

Published Date: 2 July 2019

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L

Neuropsychiatric Disease and Treatment 2019, 15:1723-1736

Published Date: 1 July 2019

Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population

García-de la Cruz DD, Juárez-Rojop IE, Tovilla-Zárate CA, Martínez-Magaña JJ, Genis-Mendoza AD, Nicolini H, González-Castro TB, Guzmán-Priego CG, López-Martínez NA, Hernández-Cisneros JA, Caballero-Prado F

Neuropsychiatric Disease and Treatment 2019, 15:1717-1722

Published Date: 28 June 2019

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder

Wang M, Wei J, Yang X, Ni P, Wang Y, Zhao L, Deng W, Guo W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1695-1700

Published Date: 27 June 2019

Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia

Si T, Zhuo J, Feng Y, Lu H, Hong D, Zhang L

Neuropsychiatric Disease and Treatment 2019, 15:1685-1694

Published Date: 27 June 2019

Reduction in apathy following epilepsy surgery

Mah L, Swearer J, Phillips CA, Benjamin S

Neuropsychiatric Disease and Treatment 2019, 15:1679-1684

Published Date: 28 June 2019

The role of long noncoding RNA in traumatic brain injury

Li Z, Han K, Zhang D, Chen J, Xu Z, Hou L

Neuropsychiatric Disease and Treatment 2019, 15:1671-1677

Published Date: 28 June 2019

The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies

Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ

Neuropsychiatric Disease and Treatment 2019, 15:1659-1669

Published Date: 24 June 2019

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder

Bo Q, Tian L, Li F, Mao Z, Wang Z, Ma X, Wang C

Neuropsychiatric Disease and Treatment 2019, 15:1649-1657

Published Date: 24 June 2019

The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia

Zhang C, Zang Y, Song Q, Li H, Hu L, Zhao W, Feng S, Gu F, Zhao F, Zhang C

Neuropsychiatric Disease and Treatment 2019, 15:1639-1647

Published Date: 24 June 2019

Correlation between precontemplation and alpha activity in gambling disorder

Lee J, Choi SW, Kim KM, Lee YS, Kim JW

Neuropsychiatric Disease and Treatment 2019, 15:1629-1637

Published Date: 21 June 2019

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

de Filippis R, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, De Fazio P

Neuropsychiatric Disease and Treatment 2019, 15:1605-1627

Published Date: 19 June 2019

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies

Madera JJ, Such P, Zhao C, Baker RA

Neuropsychiatric Disease and Treatment 2019, 15:1593-1604

Published Date: 18 June 2019

Status epilepticus in patients with genetic (idiopathic) generalized epilepsy

Bosak M, Pawełczak D, Słowik A

Neuropsychiatric Disease and Treatment 2019, 15:1585-1592

Published Date: 20 June 2019

Serum lipid profiles and post-stroke depression in acute ischemic stroke patients

Shen H, Tu X, Luan X, Zeng Y, He J, Tang W

Neuropsychiatric Disease and Treatment 2019, 15:1573-1583

Published Date: 17 June 2019

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder

Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2019, 15:1537-1545

Published Date: 6 June 2019

GABAB receptor activation ameliorates spatial memory impairments in stress-exposed rats

Sahraei H, Askaripour M, Esmaeilpour K, Shahsavari F, Rajabi S, Moradi-Kor N

Neuropsychiatric Disease and Treatment 2019, 15:1497-1506

Published Date: 30 May 2019

Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey

Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D’Souza J

Neuropsychiatric Disease and Treatment 2019, 15:1487-1495

Published Date: 30 May 2019

Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis

Ahn HJ, Shin MK, Seo JK, Jeong SJ, Cho AR, Choi SH, Lew BL

Neuropsychiatric Disease and Treatment 2019, 15:1469-1478

Published Date: 28 May 2019

HO-1 protects the nerves of rats with cerebral hemorrhage by regulating the PI3K/AKT signaling pathway

Zhao Q, Qu R, Teng L, Yin C, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:1459-1468

Published Date: 28 May 2019

Clinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome

Amin OA, Abouzeid SM, Ali SA, Amin BA, Alswat KA

Neuropsychiatric Disease and Treatment 2019, 15:1421-1426

Published Date: 27 May 2019

The relationship between serum cobalamin, folic acid, and homocysteine and the risk of post-cardiac surgery delirium

Vahdat Shariatpanahi M, Velayati A, Jamalian SA, Babevaynejad M, Vahdat Shariatpanahi Z

Neuropsychiatric Disease and Treatment 2019, 15:1413-1419

Published Date: 23 May 2019

Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments

Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI

Neuropsychiatric Disease and Treatment 2019, 15:1381-1402

Published Date: 21 May 2019

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU

Neuropsychiatric Disease and Treatment 2019, 15:1365-1379

Published Date: 21 May 2019

Structural changes in white matter lesion patients and their correlation with cognitive impairment

Wang J, Liang Y, Chen H, Wang W, Wang Y, Liang Y, Zhang Y

Neuropsychiatric Disease and Treatment 2019, 15:1355-1363

Published Date: 21 May 2019

What are the links between hypoxia and Alzheimer’s disease?

Lall R, Mohammed R, Ojha U

Neuropsychiatric Disease and Treatment 2019, 15:1343-1354

Published Date: 21 May 2019

Cognitive impairment in eating disorder patients of short and long-term duration: a case–control study

Grau A, Magallón-Neri E, Faus G, Feixas G

Neuropsychiatric Disease and Treatment 2019, 15:1329-1341

Published Date: 21 May 2019

Risk factors for delirium: are therapeutic interventions part of it?

Xing J, Yuan Z, Jie Y, Liu Y, Wang M, Sun Y

Neuropsychiatric Disease and Treatment 2019, 15:1321-1327

Published Date: 17 May 2019

A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder

Nikolakaros G, Kurki T, Myllymäki A, Ilonen T

Neuropsychiatric Disease and Treatment 2019, 15:1311-1320

Published Date: 22 May 2019

Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy

Pinter A, Szatmari Jr S, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T

Neuropsychiatric Disease and Treatment 2019, 15:1287-1310

Published Date: 17 May 2019

Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives

Tastevin M, Spatola G, Régis J, Lançon C, Richieri R

Neuropsychiatric Disease and Treatment 2019, 15:1259-1272

Published Date: 15 May 2019

Cognitive impairment in depression: recent advances and novel treatments

Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A

Neuropsychiatric Disease and Treatment 2019, 15:1249-1258

Published Date: 10 May 2019

Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach

Vähäniemi A, Välimäki M, Pekurinen V, Anttila M, Lantta T

Neuropsychiatric Disease and Treatment 2019, 15:1239-1248

Published Date: 9 May 2019

Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder

Dell’Osso L, Cremone IM, Carpita B, Dell’Oste V, Muti D, Massimetti G, Barlati S, Vita A, Fagiolini A, Carmassi C, Gesi C

Neuropsychiatric Disease and Treatment 2019, 15:1231-1238

Published Date: 13 May 2019

Chronic stress increases susceptibility to food addiction by increasing the levels of DR2 and MOR in the nucleus accumbens

Wei NL, Quan ZF, Zhao T, Yu XD, Xie Q, Zeng J, Ma FK, Wang F, Tang QS, Wu H, Zhu JH

Neuropsychiatric Disease and Treatment 2019, 15:1211-1229

Published Date: 8 May 2019

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC

Neuropsychiatric Disease and Treatment 2019, 15:1193-1209

Published Date: 8 May 2019

The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms

Liu P, Li G, Zhang A, Sun N, Kang L, Yang C, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2019, 15:1181-1191

Published Date: 9 May 2019

The relationships between video game experience and cognitive abilities in adolescents

Özçetin M, Gümüştaş F, Çağ Y, Gökbay İZ, Özmel A

Neuropsychiatric Disease and Treatment 2019, 15:1171-1180

Published Date: 8 May 2019

Health, functionality, and social support in families with a child with a neurodevelopmental disorder – a pilot study

Cavonius-Rintahaka D, Aho AL, Voutilainen A, Billstedt E, Gillberg C

Neuropsychiatric Disease and Treatment 2019, 15:1151-1161

Published Date: 8 May 2019

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial

Zhuo K, Tang Y, Song Z, Wang Y, Wang J, Qian Z, Li H, Xiang Q, Chen T, Yang Z, Xu Y, Fan X, Wang J, Liu D

Neuropsychiatric Disease and Treatment 2019, 15:1141-1150

Published Date: 8 May 2019

Personality associated with depressive status in individuals with type 2 diabetes mellitus

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N

Neuropsychiatric Disease and Treatment 2019, 15:1133-1139

Published Date: 3 May 2019

Effects of transection of cervical sympathetic trunk on cognitive function of traumatic brain injury rats

Long J, He CJ, Dai H, Kang XG, Zou JF, Ye SL, Yu Q

Neuropsychiatric Disease and Treatment 2019, 15:1121-1131

Published Date: 3 May 2019

Detection of cognitive impairment using a machine-learning algorithm [Corrigendum]

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2019, 15:1119-1120

Published Date: 1 May 2019

Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques

Deng F, Pan J, Zheng P, Xia J, Yin B, Liang W, Li Y, Wu J, Xu F, Wu Q, Qu C, Li W, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:1077-1088

Published Date: 1 May 2019

Deep brain stimulation in Tourette’s syndrome: evidence to date

Casagrande SCB, Cury RG, Alho EJL, Fonoff ET

Neuropsychiatric Disease and Treatment 2019, 15:1061-1075

Published Date: 29 April 2019

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia

Pietrini F, Albert U, Ballerini A, Calò P, Maina G, Pinna F, Vaggi M, Boggian I, Fontana M, Moro C, Carpiniello B

Neuropsychiatric Disease and Treatment 2019, 15:1045-1060

Published Date: 30 April 2019

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:1031-1044

Published Date: 24 April 2019

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis

Xu YL, Hu YY, Li JW, Zhou L, Li L, Niu YM

Neuropsychiatric Disease and Treatment 2019, 15:1015-1029

Published Date: 23 April 2019

The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease

Wang J, Chen X, Liao J, Zhou L, Liao S, Shan Y, Lu Z, Tao J

Neuropsychiatric Disease and Treatment 2019, 15:1009-1014

Published Date: 18 April 2019

Abnormal resting-state functional connectivity of amygdala subregions in patients with obstructive sleep apnea

Yu H, Chen L, Li H, Xin H, Zhang J, Wei Z, Peng D

Neuropsychiatric Disease and Treatment 2019, 15:977-987

Published Date: 17 April 2019

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study

Yuan H, Zhu X, Luo Q, Halim A, Halim M, Yao H, Cai Y, Shi S

Neuropsychiatric Disease and Treatment 2019, 15:957-966

Published Date: 16 April 2019

Cortical thinning and flattening in schizophrenia and their unaffected parents

Yan J, Cui Y, Li Q, Tian L, Liu B, Jiang T, Zhang D, Yan H

Neuropsychiatric Disease and Treatment 2019, 15:935-946

Published Date: 12 April 2019

Minimally invasive evacuation of spontaneous supratentorial intracerebral hemorrhage by transcranial neuroendoscopic approach

Cai Q, Guo Q, Li Z, Wang W, Zhang W, Ji B, Chen Z, Liu J

Neuropsychiatric Disease and Treatment 2019, 15:919-925

Published Date: 11 April 2019

Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Shams J, Asadi S, Ahmadiani A

Neuropsychiatric Disease and Treatment 2019, 15:895-904

Published Date: 10 April 2019

Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P, Wang Y, Wei Y, Fang L, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:867-881

Published Date: 10 April 2019

Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients

Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, Zhang B

Neuropsychiatric Disease and Treatment 2019, 15:857-865

Published Date: 8 April 2019

Lifetime predictors of stroke in subjects without a diagnosis of hypertension: the aerobics center longitudinal study

Cavero-Redondo I, Sui X, Blair SN, Lavie CJ, Álvarez-Bueno C, Martínez-Vizcaíno V

Neuropsychiatric Disease and Treatment 2019, 15:849-856

Published Date: 8 April 2019

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients

Galińska-Skok B, Szulc A, Małus A, Konarzewska B, Cwalina U, Tarasów E, Waszkiewicz N

Neuropsychiatric Disease and Treatment 2019, 15:839-847

Published Date: 8 April 2019

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients

Szász JA, Orbán-Kis K, Constantin VA, Péter C, Bíró I, Mihály I, Szegedi K, Balla A, Szatmári S

Neuropsychiatric Disease and Treatment 2019, 15:831-838

Published Date: 5 April 2019

Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment

Jarzemski P, Brzoszczyk B, Popiołek A, Stachowicz-Karpińska A, Gołota S, Bieliński M, Borkowska A

Neuropsychiatric Disease and Treatment 2019, 15:819-829

Published Date: 5 April 2019

Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study

Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X

Neuropsychiatric Disease and Treatment 2019, 15:779-783

Published Date: 2 April 2019

Relationships between Internet addiction and clinicodemographic and behavioral factors

ElSalhy M, Miyazaki T, Noda Y, Nakajima S, Nakayama H, Mihara S, Kitayuguchi T, Higuchi S, Muramatsu T, Mimura M

Neuropsychiatric Disease and Treatment 2019, 15:739-752

Published Date: 26 March 2019

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation

Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E

Neuropsychiatric Disease and Treatment 2019, 15:731-737

Published Date: 22 March 2019

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease

Fujimoto N, Nakamura H, Tsuda T, Wakutani Y, Takao T

Neuropsychiatric Disease and Treatment 2019, 15:713-720

Published Date: 20 March 2019

Repetitive transcranial magnetic stimulation in trauma-related conditions

Namgung E, Kim M, Yoon S

Neuropsychiatric Disease and Treatment 2019, 15:701-712

Published Date: 19 March 2019

Identification of key genes, pathways and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis

Ma K, Zhang HX, Wei GH, Dong ZF, Zhao HJ, Han XC, Song XB, Zhang HL, Zong X, Baloch Z, Wang SJ

Neuropsychiatric Disease and Treatment 2019, 15:685-700

Published Date: 14 March 2019

The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis

Zhao L, Li X, Liu G, Han B, Wang J, Jiang X

Neuropsychiatric Disease and Treatment 2019, 15:675-684

Published Date: 12 March 2019

Effects of prenatal exposure to temephos on behavior and social interaction

Martins Laurentino AO, Durante de Medeiros F, de Oliveira J, da Rosa N, Mateus Gomes T, de Medeiros Peretti E, Somariva Prophiro J, Fortunato JJ

Neuropsychiatric Disease and Treatment 2019, 15:669-673

Published Date: 11 March 2019

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment

Masi G, Fantozzi P, Villafranca A, Tacchi A, Ricci F, Ruglioni L, Inguaggiato E, Pfanner C, Cortese S

Neuropsychiatric Disease and Treatment 2019, 15:663-667

Published Date: 7 March 2019

GSK-3β and BDNF genes may not be associated with venlafaxine treatment response in Chinese of Han ethnicity

Sun Q, Yuan F, Ren D, Ma G, Yang F, Wu X, He L, He G

Neuropsychiatric Disease and Treatment 2019, 15:657-661

Published Date: 7 March 2019

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum]

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2019, 15:655-656

Published Date: 5 March 2019

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis

Urban-Kowalczyk M, Strzelecki D, Śmigielski J, Kotlicka-Antczak M

Neuropsychiatric Disease and Treatment 2019, 15:647-654

Published Date: 5 March 2019

Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints

Kim JW, Byun MS, Yi D, Lee JH, Ko K, Jung G, Lee DY

Neuropsychiatric Disease and Treatment 2019, 15:637-645

Published Date: 4 March 2019

Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study

Asiri S, Altwaijri WA, Ba-Armah D, Al Rumayyan A, Alrifai MT, Salam M, Almutairi AF

Neuropsychiatric Disease and Treatment 2019, 15:627-635

Published Date: 1 March 2019

Social cognitive training for adults with Noonan syndrome: a feasibility study

Roelofs RL, Wingbermühle E, Kessels RPC, Egger JIM

Neuropsychiatric Disease and Treatment 2019, 15:611-626

Published Date: 26 February 2019

Racial and ethnic differences in depression: current perspectives

Bailey RK, Mokonogho J, Kumar A

Neuropsychiatric Disease and Treatment 2019, 15:603-609

Published Date: 22 February 2019

Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats

Alachkar A, Khan N, Łażewska D, Kieć-Kononowicz K, Sadek B

Neuropsychiatric Disease and Treatment 2019, 15:531-542

Published Date: 20 February 2019

The interactive effects of stress and coping style on cognitive function in patients with schizophrenia

Zhu X, Xu X, Xu C, Zhang J, Zhang X, Ma L, Liu J, Wang K

Neuropsychiatric Disease and Treatment 2019, 15:523-530

Published Date: 21 February 2019

Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study

Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I

Neuropsychiatric Disease and Treatment 2019, 15:511-521

Published Date: 20 February 2019

Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia

Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H

Neuropsychiatric Disease and Treatment 2019, 15:491-502

Published Date: 14 February 2019

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia

She S, Zhang B, Mi L, Li H, Kuang Q, Bi T, Zheng Y

Neuropsychiatric Disease and Treatment 2019, 15:481-489

Published Date: 18 February 2019

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress

Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S

Neuropsychiatric Disease and Treatment 2019, 15:469-480

Published Date: 13 February 2019

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression

Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ

Neuropsychiatric Disease and Treatment 2019, 15:457-468

Published Date: 13 February 2019

The effect of night shift on sleep quality and depressive symptoms among Chinese nurses

Dai C, Qiu H, Huang Q, Hu P, Hong X, Tu J, Xie Q, Li H, Ren W, Ni S, Chen F

Neuropsychiatric Disease and Treatment 2019, 15:435-440

Published Date: 7 February 2019

Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients

Ittasakul P, Likitnukul A, Pitidhammabhorn U, Waleeprakhon P, Goldman MB

Neuropsychiatric Disease and Treatment 2019, 15:429-434

Published Date: 7 February 2019

Analysis of motor performance in individuals with cerebral palsy using a non-immersive virtual reality task – a pilot study

Martins FPA, Massetti T, Crocetta TB, Bianchi Lopes P, da Silva AA, Figueiredo EF, de Abreu LC, da Silva TD, Monteiro CBM

Neuropsychiatric Disease and Treatment 2019, 15:417-428

Published Date: 4 February 2019

HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model

Zhang YN, Dong HT, Duan L, Niu L, Yuan GQ, Dai JQ, Hou BR, Pan YW

Neuropsychiatric Disease and Treatment 2019, 15:405-416

Published Date: 4 February 2019

Psychiatric comorbidities in patients with intentional methanol intoxication

Yang WS, Yen TH, Juang YY, Lee SH, Wang BH, Lee CP

Neuropsychiatric Disease and Treatment 2019, 15:397-402

Published Date: 31 January 2019

Clinical factors influencing resilience in patients with anorexia nervosa

Kane C, Tomotake M, Hamatani S, Chiba S, Kameoka N, Watanabe S, Nakataki M, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:391-395

Published Date: 30 January 2019

Evacuation of chronic and subacute subdural hematoma via transcranial neuroendoscopic approach

Cai Q, Guo Q, Zhang F, Sun D, Zhang W, Ji B, Chen Z, Mao S

Neuropsychiatric Disease and Treatment 2019, 15:385-390

Published Date: 30 January 2019

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms

Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y

Neuropsychiatric Disease and Treatment 2019, 15:375-383

Published Date: 29 January 2019

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication

Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M

Neuropsychiatric Disease and Treatment 2019, 15:349-355

Published Date: 25 January 2019

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse

Svob Strac D, Nedic Erjavec G, Nikolac Perkovic M, Nenadic-Sviglin K, Konjevod M, Grubor M, Pivac N

Neuropsychiatric Disease and Treatment 2019, 15:339-347

Published Date: 24 January 2019

Effects of early administration of insulin-like growth factor-1 on cognitive function in septic encephalopathy

Yang Y, Liang S, Li Y, Gao F, Cao Y, Zhao X, Gao G, Li L

Neuropsychiatric Disease and Treatment 2019, 15:323-337

Published Date: 23 January 2019

Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation

Dowlati Y, de Jesus DR, Selby P, Fan I, Meyer JH

Neuropsychiatric Disease and Treatment 2019, 15:311-321

Published Date: 23 January 2019

Cytokines and chemokines expression in serum of patients with neuromyelitis optica

Ai NP, Liu HJ, Zhou HF, Lin DH, Wang JQ, Yang M, Song HG, Sun MM, Xu QG, Wei SH

Neuropsychiatric Disease and Treatment 2019, 15:303-310

Published Date: 21 January 2019

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:293-301

Published Date: 21 January 2019

Altered intrinsic brain activity in patients with toothaches using the amplitude of low-frequency fluctuations: a resting-state fMRI study

Yang J, Li B, Yu QY, Ye L, Zhu PW, Shi WQ, Yuan Q, Min YL, He YL, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:283-291

Published Date: 18 January 2019

Frequency-dependent neural activity in primary angle-closure glaucoma

Jiang F, Yu C, Zuo MJ, Zhang C, Wang Y, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2019, 15:271-282

Published Date: 18 January 2019

Association between anxious distress in a major depressive episode and bipolarity

Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K

Neuropsychiatric Disease and Treatment 2019, 15:267-270

Published Date: 15 January 2019

Serum BICC1 levels are significantly different in various mood disorders

Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:259-265

Published Date: 15 January 2019

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder

Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J

Neuropsychiatric Disease and Treatment 2019, 15:233-240

Published Date: 14 January 2019

Lower vitamin D levels are associated with depression in patients with gout

Zhou Q, Shao Y, Gan Z, Fang L

Neuropsychiatric Disease and Treatment 2019, 15:227-231

Published Date: 14 January 2019

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1

Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E

Neuropsychiatric Disease and Treatment 2019, 15:219-226

Published Date: 14 January 2019

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele

Yin J, Feng W, Yuan H, Yuan J, Wu Y, Liu X, Jin C, Cheng Z

Neuropsychiatric Disease and Treatment 2019, 15:213-218

Published Date: 11 January 2019

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:205-211

Published Date: 9 January 2019

Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings

Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S

Neuropsychiatric Disease and Treatment 2019, 15:199-204

Published Date: 7 January 2019

The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors

Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G

Neuropsychiatric Disease and Treatment 2019, 15:177-182

Published Date: 4 January 2019

Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment

Albai O, Frandes M, Timar R, Roman D, Timar B

Neuropsychiatric Disease and Treatment 2019, 15:167-175

Published Date: 3 January 2019

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang YL, Chen K, Cheng Y, Chen W

Neuropsychiatric Disease and Treatment 2019, 15:157-166

Published Date: 31 December 2018

Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis

Xu F, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2019, 15:143-155

Published Date: 28 December 2018

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:137-142

Published Date: 27 December 2018

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R

Neuropsychiatric Disease and Treatment 2019, 15:127-135

Published Date: 27 December 2018

Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning

Carmassi C, Dell’Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell’Osso L

Neuropsychiatric Disease and Treatment 2019, 15:115-125

Published Date: 24 December 2018

Poststroke epilepsy: current perspectives on diagnosis and treatment

Sarecka-Hujar B, Kopyta I

Neuropsychiatric Disease and Treatment 2019, 15:95-103

Published Date: 24 December 2018

Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test

Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC

Neuropsychiatric Disease and Treatment 2019, 15:83-94

Published Date: 24 December 2018

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder

Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R

Neuropsychiatric Disease and Treatment 2019, 15:75-82

Published Date: 21 December 2018

The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale

Wang X, Dai L, Yin M, Deng YL

Neuropsychiatric Disease and Treatment 2019, 15:57-67

Published Date: 21 December 2018

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

Dong H, Fan S, Luo Y, Peng B

Neuropsychiatric Disease and Treatment 2019, 15:33-36

Published Date: 19 December 2018

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD

Neuropsychiatric Disease and Treatment 2019, 15:1-19

Published Date: 17 December 2018